Hansson Brian (Bryan Hanson)

Hansson Brian (Bryan Hanson)

Biography

2015

In 2015 when the producer of the medical equipment Covidien was sold to Medtronic, Brian Hansson joined the last, having headed division of Minimally Invasive Therapies Group which annual revenues were $9 billion.

Before arrival to Medtronic it was the vice president of group on release of the medical equipment of Covidien. Under the leadership of Hansson there was a merge of two the business directions, largest in the company — production of surgical instruments and electric devices.

2017: Appointment of Zimmer Biomet as the head

In December, 2017 Brian Hansson headed Zimmer Biomet corporation which is engaged in development and production for orthopedics and traumatology.

On December 19 Hansson officially became the president and the CEO of Zimmer Biomet and also joined the companies the board. Daniel Florin who since July 11, 2017 temporarily fulfilled duties of the CEO returned on the positions of the senior vice president and the chief financial officer taking earlier.

The chairman of the board of directors of Zimmer Biomet Larry Glasscock called Hansson the best candidate for a position of the company executive.

Brian is the checked head, the having successful experience of management, growth and transformation of business on release of the medical equipment for achievement of the high level of innovations, commercial success and profit — Glasskok noted.

According to the Morningstar edition, some analysts consider Hansson's arrival to the leadership of Zimmer Biomet in attempt of the company to expand the client audience, having added to it heads of medical institutions, purchasing departments, etc.

The previous CEO David Dvorakits was considered as more conservative head as adhered to work generally with surgeons-orthopedists.^[1]

Notes